4F1S | Crystal structure of human PI3K-gamma in complex with a pyridyl-triazine-sulfonamide inhibitor | date | 2012-05-07 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Whittington, D.A., Tang, J., Yakowec, P. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 3.00 | ||||||||||||
ligand | F1S, SO4 | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Synthesis and structure-activity relationships of dual PI3K/mTOR inhibitors based on a 4-amino-6-methyl-1,3,5-triazine sulfonamide scaffold., Wurz RP, Liu L, Yang K, Nishimura N, Bo Y, Pettus LH, Caenepeel S, Freeman DJ, McCarter JD, Mullady EL, Miguel TS, Wang L, Zhang N, Andrews KL, Whittington DA, Jiang J, Subramanian R, Hughes PE, Norman MH, Bioorg Med Chem Lett. 2012 Jul 3. PMID:22832322 |
Data retrieval |
View 4F1S in 3D |
Visual 3D analysis of 4F1S |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4F1S |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |